This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

24-26 Feb, 2026

Grand Nikko Tokyo DaibaTokyo

Shiro Akinaga, PhD
NANO MRNA, Co., Ltd. における President and CEO
スピーカー

アジェンダセッション

Advancing Oligonucleotide and mRNA Therapeutics: TUG1 ASO for Recurrent Glioblastoma and Runx1 mRNA for Knee Osteoarthritis
25 2月, 9:15am
セッションを見る

このイベントで

前へ

次へ

Group Lead Chemistry-QC

PYC Therapeutics